Law Banning Flavored Tobacco Products in San Diego Signed into Law

News
Jun.05.2022
San Diego Mayor Todd Gloria signed into law Friday a bill that will stop the sale of flavored tobacco in the city.
Law Banning Flavored Tobacco Products in San Diego Signed into Law

 

San Diego City Councilwomen Marni von Wilpert and Jennifer Campbell joined San Diego School Board Trustees on Friday to announce the Stop Adolescent Addiction to Flavored E-Cigarettes Act was officially signed into law by Gloria.

The City Council approved the SAAFE Act, introduced by von Wilpert, to prohibit the sale of specified flavored tobacco and nicotine products in the city. It targets flavored tobacco and nicotine products that “appeal to children through candy and fruit flavors, as an attempt to hide the harshness of nicotine and as a direct attempt to appeal to a younger audience,” von Wilpert said.

“This new law is going to save lives and safeguard children’s health,” she said. “Our new partnership with San Diego schools will empower parents with vital health resources so we do everything possible to prevent Big Tobacco from hooking our children and hijacking their futures.”

School Board Trustees Richard Barrera and Zachary Patterson joined the councilwomen at Friday morning’s news conference to educate parents on the dangers of skyrocketing teenage nicotine addiction and highlighted resources to combat youth nicotine use.

 

Source:timesofsandiego

 

STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
Scandinavian Tobacco Group UK (STG UK) has announced a rebrand across its XQS nicotine pouch range. The updated packaging will be visible at retail from March, with the recommended retail price remaining £5.50. The new packs feature a bolder logo and glossy textures, retain nicotine strength indicators, and add a side flavour profile indicator to show the flavour type.
Feb.28 by 2FIRSTS.ai
Alabama SB9 would treat vaping like smoking under indoor public-space restrictions
Alabama SB9 would treat vaping like smoking under indoor public-space restrictions
Alabama’s Senate Bill 9 would modernize the state’s indoor air quality laws by treating electronic nicotine delivery systems, including e-cigarettes and vape pens, the same as traditional tobacco smoking in indoor public spaces. Sponsored by Sen.
Jan.05 by 2FIRSTS.ai
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
Philippines DOH reiterates: vaping is not safer than smoking, citing irreversible health risks
The Philippine Department of Health reiterated Saturday that vaping should not be promoted as an alternative to cigarette smoking, Health Secretary Teodoro “Ted” Herbosa said in a radio interview, according to the Tribune. Herbosa said both vaping and smoking pose irreversible health risks and cited E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI), claiming it led to the death of a 22-year-old male with no smoking history in 2025.
Feb.28 by 2FIRSTS.ai
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
Feb.09
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
IQOS Japan launches three ILUMA i custom bundle sets with leather wrap and premium ring accessories, on sale from Jan 29
According to IQOS Japan’s official website, the company has introduced three custom bundle sets for its IQOS ILUMA i lineup, combining devices with accessories as bundled offerings, and began rolling them out across multiple sales channels from Jan. 29.
Jan.29 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11